Noom Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: coaching bundled into the price rather than sold separately
Noom's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
then $179/mo ongoing
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Prices checked September 2026
Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.
Is Noom legit?
Yes. Noom is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 6.9/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Noom promo or coupon code?
Noom has no coupon code to enter. New patients are currently quoted $79 for the first month, then $179 a month, and the discount applies on its own. Coupon sites advertising a "Noom promo code" are not a source we can vouch for.
See how Noom compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Noom
Enhance MD
Best for: knowing which pharmacy fills the vial: it names Tru Meds Rx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Noom at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo
- What's included
- Consult · Coaching
- FDA status
- No FDA warning letters found
How Noom scores
Six columns, each one computed from something Noom has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
5.2/10$179/month is 3% below the $185 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
4.0/10The price covers clinician visits and coaching.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Noom
Last checked September 2026- Checked the listed price across 3 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Noom
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Noom involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Noom shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Noom which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes clinician visits and coaching.
- Lowest ongoing monthly price: semaglutide $179, tirzepatide $349. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Noom serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Noom
- Phone
- (888) 266-5071
- Noom offers email support
- Hours
- Phone daily 8am to 8pm ET; chat 24/7
Cancelling Noom
Taken from the terms Noom publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Refund policy
- Refunds only before a prescription is written; renewal charges are not refunded
GLP-1 medications Noom offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
The first 3 weeks of the program with 4 weeks of medication start from $149, then $349 per month plus tax on a 12-week subscription. The program also offers generic liraglutide.
The first 3 weeks with 4 weeks of medication start from $79, then $179 per month plus tax on a 12-week subscription. Compounded tirzepatide is also offered on this plan.
Check the price yourself before you pay
Every figure here was read off Noom's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $179 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Noom
Against it
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Noom charges
Two numbers matter here and only one of them is the price. $79 is the opening month; $179/month is what Noom charges after that.
- Compounded semaglutide: $149 first month, then $349/month
- Brand-name tirzepatide: $349/month
- Compounded semaglutide: $79 first month, then $179/month
For compounded semaglutide, the median across the sellers we compare is $185/month, so Noom's $179 lands mid-market. Price is unlikely to be the deciding factor.
DudeMeds dispenses semaglutide and tirzepatide from $175/month, which makes it the fair comparison to run before you commit here.
What Noom dispenses
Noom prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. The choice is between an FDA-approved pen and a compounded preparation that costs less. Compounding is lawful and often appropriate, but a compounded product is not an approved one, and the price gap is largely that difference.
Safety and disclosure
Noom tells you its price before you start the medical questionnaire. It also offers coaching as part of the plan. We found no FDA warning letters issued to Noom. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Noom will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will pay in month three.
- You need insurance to cover the cost. Check whether Noom bills your plan before you start.
It fits if
- you want a cheap way to find out whether the medication suits you before committing
- you want coaching bundled in rather than billed on top
Our read
Noom is a cheap way to start and an ordinary way to continue. Use the $79 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $179/month before you let it renew twice. Bodybuilding Health+ is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Noom's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Before you pay Noom
Starting at $79 a month. Check today's price, then start the intake.
Compare Noom head to head
The sellers closest to Noom on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Noom review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of September 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Noom's current pricing
Plans start at $79 a month. Whether you qualify is a clinician's decision, made after your intake.